Synergistic HIV latency reversal from an in vitro screen of epigenetic and kinase inhibitors

• D. Irlbeck,
• Y. Zhao,
• A. Axtman,
• B. Zuercher,
• L. Ingerman-James

Affiliations

D. Irlbeck

University of North Carolina HIV Cure Center, GlaxoSmithKline, Chapel Hill, NC, USA

Y. Zhao

GlaxoSmithKline Target Sciences-Statistics, Research Triangle Park, NC, USA

A. Axtman

University of North Carolina HIV Cure Center, Structural Genomics Consortium, Chapel Hill, NC, USA

B. Zuercher

University of North Carolina HIV Cure Center, Structural Genomics Consortium, Chapel Hill, NC, USA

L. Ingerman-James

University of North Carolina HIV Cure Center, Center for Integrative Chemical Biology and Drug Discovery, Chapel Hill, NC, USA